Literature DB >> 10207149

Direct regulatory interaction of the eyeless protein with an eye-specific enhancer in the sine oculis gene during eye induction in Drosophila.

T Niimi1, M Seimiya, U Kloter, S Flister, W J Gehring.   

Abstract

The Pax-6 gene encodes a transcription factor with two DNA-binding domains, a paired and a homeodomain, and is expressed during eye morphogenesis and development of the nervous system. Pax-6 homologs have been isolated from a wide variety of organisms ranging from flatworms to humans. Since loss-of-function mutants in insects and mammals lead to an eyeless phenotype and Pax-6 orthologs from distantly related species are capable of inducing ectopic eyes in Drosophila, we have proposed that Pax-6 is a universal master control gene for eye morphogenesis. To determine the extent of evolutionary conservation of the eye morphogenetic pathway, we have begun to identify subordinate target genes of Pax-6. Previously we have shown that expression of two genes, sine oculis (so) and eyes absent (eya), is induced by eyeless (ey), the Pax-6 homolog of Drosophila. Here we present evidence from ectopic expression studies in transgenic flies, from transcription activation studies in yeast, and from gel shift assays in vitro that the EY protein activates transcription of sine oculis by direct interaction with an eye-specific enhancer in the long intron of the so gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207149     DOI: 10.1242/dev.126.10.2253

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  55 in total

1.  Searching for the prototypic eye genetic network: Sine oculis is essential for eye regeneration in planarians.

Authors:  D Pineda; J Gonzalez; P Callaerts; K Ikeo; W J Gehring; E Salo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Expression of evolutionarily conserved eye specification genes during Drosophila embryogenesis.

Authors:  J P Kumar; K Moses
Journal:  Dev Genes Evol       Date:  2001-09       Impact factor: 0.900

3.  The eyeless homeodomain is dispensable for eye development in Drosophila.

Authors:  C Punzo; S Kurata; W J Gehring
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

4.  Conservation of Pax 6 function and upstream activation by Notch signaling in eye development of frogs and flies.

Authors:  Yasuko Onuma; Shuji Takahashi; Makoto Asashima; Shoichiro Kurata; Walter J Gehring
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

5.  Analysis of the eye developmental pathway in Drosophila using DNA microarrays.

Authors:  Lydia Michaut; Susanne Flister; Martin Neeb; Kevin P White; Ulrich Certa; Walter J Gehring
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

6.  Novel dominant-negative mutation within the six domain of the conserved eye specification gene sine oculis inhibits eye development in Drosophila.

Authors:  Kristin Roederer; Loralyn Cozy; Jason Anderson; Justin P Kumar
Journal:  Dev Dyn       Date:  2005-03       Impact factor: 3.780

7.  Dual transcriptional activities of SIX proteins define their roles in normal and ectopic eye development.

Authors:  Abigail M Anderson; Bonnie M Weasner; Brandon P Weasner; Justin P Kumar
Journal:  Development       Date:  2012-03       Impact factor: 6.868

Review 8.  Lacrimal gland development: From signaling interactions to regenerative medicine.

Authors:  Ankur Garg; Xin Zhang
Journal:  Dev Dyn       Date:  2017-08-18       Impact factor: 3.780

9.  Combinatorial control of Drosophila eye development by eyeless, homothorax, and teashirt.

Authors:  Jose Bessa; Brian Gebelein; Franck Pichaud; Fernando Casares; Richard S Mann
Journal:  Genes Dev       Date:  2002-09-15       Impact factor: 11.361

10.  Identification of transcriptional targets of the dual-function transcription factor/phosphatase eyes absent.

Authors:  Jennifer Jemc; Ilaria Rebay
Journal:  Dev Biol       Date:  2007-07-27       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.